TREATING DISEASES OF AGING AND
TREATING AGING AS DISEASE™
October 24, 2025
Immorta Bio's Newest IP + Preclinical Progress: Advancing Mitochondrial Regeneration Strategy
PR-Newswire
October 14, 2025
Immorta Bio’s Research Points to a Potential Pathway Toward "Re-Awakening" Coma Patients
PR Newswire
Read MoreSeptember 24, 2025
Immorta Bio Reports Activity of SenoVax™ in CTE Model
PR Newswire
Read MoreSeptember 17, 2025
Lung Cancer Pioneer Dr. Gilberto Lopes Joins Longevity Company
YAHOO! Finance
Read MoreNever Miss A Headline
Joining Immorta Bio's News List Puts You At The Forefront Of Our Longevity Journey
Technologies
SenoVax™
Autologous Approach To Eliminate Senescent Cells
StemCellRevivify™
Rebuild Damaged Organs and Tissues With Stem Cells
Become Part of Our Longevity Mission
We’re building the future of human health. Join our growing team of scientists, creatives, and innovators reshaping longevity from the inside out.
.jpeg)
